Our first fund, UpStart Life Sciences Capital, L.P. invests primarily in seed and early-stage healthcare companies, based on breakthrough technologies from major research universities, centered around Utah and neighboring states. 

​

We invest in opportunities such as medical devices, drug delivery systems, and diagnostics, as well as longer range investments in biopharma products and platforms. 

​

Central to our strategy is the belief that significantly more value can be created from the formation and initial management of leading edge life science companies than from traditional venture capital investing in pre-existing companies, whether at early or later stages.